ArticleBiomedicines2023

Reinitiation and Subsequent Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers among New and Prevalent Users Aged 65 Years or More with Peripheral Arterial Disease.

Martin Wawruch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.